545 related articles for article (PubMed ID: 30539459)
21. High-throughput sequencing technologies.
Reuter JA; Spacek DV; Snyder MP
Mol Cell; 2015 May; 58(4):586-97. PubMed ID: 26000844
[TBL] [Abstract][Full Text] [Related]
22. Next-generation sequencing in the clinic: promises and challenges.
Xuan J; Yu Y; Qing T; Guo L; Shi L
Cancer Lett; 2013 Nov; 340(2):284-95. PubMed ID: 23174106
[TBL] [Abstract][Full Text] [Related]
23. Current state-of-art of sequencing technologies for plant genomics research.
Thudi M; Li Y; Jackson SA; May GD; Varshney RK
Brief Funct Genomics; 2012 Jan; 11(1):3-11. PubMed ID: 22345601
[TBL] [Abstract][Full Text] [Related]
24. NGS for Sequence Variants.
Teng S
Adv Exp Med Biol; 2016; 939():1-20. PubMed ID: 27807741
[TBL] [Abstract][Full Text] [Related]
25. Implementation of cancer next-generation sequencing testing in a community hospital.
Akkari Y; Smith T; Westfall J; Lupo S
Cold Spring Harb Mol Case Stud; 2019 Jun; 5(3):. PubMed ID: 31160354
[TBL] [Abstract][Full Text] [Related]
26. Next generation mapping reveals novel large genomic rearrangements in prostate cancer.
Jaratlerdsiri W; Chan EKF; Petersen DC; Yang C; Croucher PI; Bornman MSR; Sheth P; Hayes VM
Oncotarget; 2017 Apr; 8(14):23588-23602. PubMed ID: 28423598
[TBL] [Abstract][Full Text] [Related]
27. Next-generation sequencing (NGS) in the microbiological world: How to make the most of your money.
Vincent AT; Derome N; Boyle B; Culley AI; Charette SJ
J Microbiol Methods; 2017 Jul; 138():60-71. PubMed ID: 26995332
[TBL] [Abstract][Full Text] [Related]
28. Tearing down the walls: FDA approves next generation sequencing (NGS) assays for actionable cancer genomic aberrations.
Allegretti M; Fabi A; Buglioni S; Martayan A; Conti L; Pescarmona E; Ciliberto G; Giacomini P
J Exp Clin Cancer Res; 2018 Mar; 37(1):47. PubMed ID: 29506529
[TBL] [Abstract][Full Text] [Related]
29. Lake Louise mutation detection meeting 2013: clinical translation of next-generation sequencing requires optimization of workflows and interpretation of variants.
Smith A; Boycott KM; Jarinova O
Hum Mutat; 2014 Feb; 35(2):265-9. PubMed ID: 24282140
[TBL] [Abstract][Full Text] [Related]
30. ClinQC: a tool for quality control and cleaning of Sanger and NGS data in clinical research.
Pandey RV; Pabinger S; Kriegner A; Weinhäusel A
BMC Bioinformatics; 2016 Feb; 17():56. PubMed ID: 26830926
[TBL] [Abstract][Full Text] [Related]
31. Genomic Analysis of Childhood Brain Tumors: Methods for Genome-Wide Discovery and Precision Medicine Become Mainstream.
Mack SC; Northcott PA
J Clin Oncol; 2017 Jul; 35(21):2346-2354. PubMed ID: 28640705
[TBL] [Abstract][Full Text] [Related]
32. Ten years of next-generation sequencing technology.
van Dijk EL; Auger H; Jaszczyszyn Y; Thermes C
Trends Genet; 2014 Sep; 30(9):418-26. PubMed ID: 25108476
[TBL] [Abstract][Full Text] [Related]
33. Clinical Applications of Next-Generation Sequencing.
Rebollar-Vega RG; Arriaga-Canon C; de la Rosa-Velázquez IA
Rev Invest Clin; 2018; 70(4):153-157. PubMed ID: 30067721
[TBL] [Abstract][Full Text] [Related]
34. Introduction to next-generation nucleic acid sequencing in cardiovascular disease research.
Diaw L; Youngblood V; Taylor JG
Methods Mol Biol; 2013; 1027():157-79. PubMed ID: 23912986
[TBL] [Abstract][Full Text] [Related]
35. Sequencing technologies and genome sequencing.
Pareek CS; Smoczynski R; Tretyn A
J Appl Genet; 2011 Nov; 52(4):413-35. PubMed ID: 21698376
[TBL] [Abstract][Full Text] [Related]
36. A comparison of tools for the simulation of genomic next-generation sequencing data.
Escalona M; Rocha S; Posada D
Nat Rev Genet; 2016 Aug; 17(8):459-69. PubMed ID: 27320129
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive elaboration of database resources utilized in next-generation sequencing-based tumor somatic mutation detection.
Gao P; Zhang R; Li J
Biochim Biophys Acta Rev Cancer; 2019 Aug; 1872(1):122-137. PubMed ID: 31265877
[TBL] [Abstract][Full Text] [Related]
38. Immunoinformatics and epitope prediction in the age of genomic medicine.
Backert L; Kohlbacher O
Genome Med; 2015 Nov; 7():119. PubMed ID: 26589500
[TBL] [Abstract][Full Text] [Related]
39. Next-generation sequencing technologies: An overview.
Hu T; Chitnis N; Monos D; Dinh A
Hum Immunol; 2021 Nov; 82(11):801-811. PubMed ID: 33745759
[TBL] [Abstract][Full Text] [Related]
40. MutAid: Sanger and NGS Based Integrated Pipeline for Mutation Identification, Validation and Annotation in Human Molecular Genetics.
Pandey RV; Pabinger S; Kriegner A; Weinhäusel A
PLoS One; 2016; 11(2):e0147697. PubMed ID: 26840129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
